These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6217773)

  • 1. Down's syndrome, aging, and Alzheimer's disease: a clinical review.
    Lott IT
    Ann N Y Acad Sci; 1982; 396():15-27. PubMed ID: 6217773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slowed synthesis of DNA and methionine is a pathogenetic mechanism common to dementia in Down's syndrome, AIDS and Alzheimer's disease?
    Regland B; Gottfries CG
    Med Hypotheses; 1992 May; 38(1):11-9. PubMed ID: 1535413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
    Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
    Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging analysis of age-related changes in the brains of individuals with Down's syndrome.
    Kesslak JP; Nagata SF; Lott I; Nalcioglu O
    Neurology; 1994 Jun; 44(6):1039-45. PubMed ID: 8208396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dementia of Down's syndrome and its relevance to aetiological studies of Alzheimer's disease.
    Whalley LJ
    Ann N Y Acad Sci; 1982; 396():39-53. PubMed ID: 6217776
    [No Abstract]   [Full Text] [Related]  

  • 6. Apoptosis in Down's syndrome: lessons from studies of human and mouse models.
    Rueda N; Flórez J; Martínez-Cué C
    Apoptosis; 2013 Feb; 18(2):121-34. PubMed ID: 23224708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of gene expression in Down's syndrome (DS) brains: its significance in neurodegeneration.
    Sawa A
    J Neural Transm Suppl; 2001; (61):361-71. PubMed ID: 11771759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic profile of plaques and neurofibrillary tangles in the amygdala in Down's syndrome: a comparison with Alzheimer's disease.
    Murphy GM; Eng LF; Ellis WG; Perry G; Meissner LC; Tinklenberg JR
    Brain Res; 1990 Dec; 537(1-2):102-8. PubMed ID: 1707726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down's syndrome and Alzheimer's dementia: defining an association.
    Heston LL
    Psychiatr Dev; 1984; 2(4):287-94. PubMed ID: 6241313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological studies of Down's syndrome and Alzheimer's disease.
    Walford RL
    Ann N Y Acad Sci; 1982; 396():95-106. PubMed ID: 6295240
    [No Abstract]   [Full Text] [Related]  

  • 11. Small cerebral hemispheres in adults with Down's syndrome: contributions of developmental arrest and lesions of Alzheimer's disease.
    de la Monte SM; Hedley-Whyte ET
    J Neuropathol Exp Neurol; 1990 Sep; 49(5):509-20. PubMed ID: 2148772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to low-frequency pulsed electromagnetic fields increases mitogen-induced lymphocyte proliferation in Down's syndrome.
    Cossarizza A; Monti D; Bersani F; Scarfi MR; Zanotti M; Cadossi R; Franceschi C
    Aging (Milano); 1991 Sep; 3(3):241-6. PubMed ID: 1837237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease.
    Arena A; Iyer AM; Milenkovic I; Kovacs GG; Ferrer I; Perluigi M; Aronica E
    Curr Alzheimer Res; 2017; 14(12):1305-1317. PubMed ID: 28720071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cerebral degeneration in Down's syndrome].
    Hirabayashi K; Ikeda K; Shimokawa K; Orthner H
    Folia Psychiatr Neurol Jpn; 1979; 33(1):81-96. PubMed ID: 156670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling the complexity of neurodegeneration in brains of subjects with Down syndrome: insights from proteomics.
    Perluigi M; Di Domenico F; Buttterfield DA
    Proteomics Clin Appl; 2014 Feb; 8(1-2):73-85. PubMed ID: 24259517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease and Down's syndrome.
    Price DL; Whitehouse PJ; Struble RG; Coyle JT; Clark AW; Delong MR; Cork LC; Hedreen JC
    Ann N Y Acad Sci; 1982; 396():145-64. PubMed ID: 6217772
    [No Abstract]   [Full Text] [Related]  

  • 17. The impact of aging on eating, drinking, and swallowing function in people with Down's syndrome.
    Lazenby T
    Dysphagia; 2008 Mar; 23(1):88-97. PubMed ID: 17694411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down's syndrome: a pathology involving the lack of balance of reactive oxygen species.
    Kedziora J; Bartosz G
    Free Radic Biol Med; 1988; 4(5):317-30. PubMed ID: 2966094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystathionine beta-synthase is enriched in the brains of Down's patients.
    Ichinohe A; Kanaumi T; Takashima S; Enokido Y; Nagai Y; Kimura H
    Biochem Biophys Res Commun; 2005 Dec; 338(3):1547-50. PubMed ID: 16274669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology.
    Margallo-Lana ML; Moore PB; Kay DW; Perry RH; Reid BE; Berney TP; Tyrer SP
    J Intellect Disabil Res; 2007 Jun; 51(Pt. 6):463-77. PubMed ID: 17493029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.